Clinical trial
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2021
- Completion date
- December 31, 2027
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b, preventable disease, vaccine, vaccination; infection